Scott B. Cameron

3.4k total citations · 1 hit paper
49 papers, 2.2k citations indexed

About

Scott B. Cameron is a scholar working on Immunology and Allergy, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Scott B. Cameron has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology and Allergy, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Scott B. Cameron's work include Food Allergy and Anaphylaxis Research (18 papers), Allergic Rhinitis and Sensitization (10 papers) and Eosinophilic Esophagitis (8 papers). Scott B. Cameron is often cited by papers focused on Food Allergy and Anaphylaxis Research (18 papers), Allergic Rhinitis and Sensitization (10 papers) and Eosinophilic Esophagitis (8 papers). Scott B. Cameron collaborates with scholars based in Canada, United States and Spain. Scott B. Cameron's co-authors include Viviana Cremasco, Sonia Quaratino, Britta Mueller, Philip J. Gotwals, Adam Crystal, Jeffrey A. Engelman, Becker Hewes, Catherine Sabatos-Peyton, Daniela Cipolletta and Glenn Dranoff and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Scott B. Cameron

45 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospects for combining targeted and conventional cancer therapy with immunotherapy

2017 766 citations Scott B. Cameron et al. profile →

Peers

Countries citing papers authored by Scott B. Cameron

Since Specialization

Citations

This map shows the geographic impact of Scott B. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott B. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott B. Cameron more than expected).

Fields of papers citing papers by Scott B. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott B. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott B. Cameron. The network helps show where Scott B. Cameron may publish in the future.

Co-authorship network of co-authors of Scott B. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Scott B. Cameron. A scholar is included among the top collaborators of Scott B. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott B. Cameron. Scott B. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Immunotherapy Should Play a Key Role in Preschool Food Allergy Management 2025 ·Clinical & Experimental Allergy ·Lianne Soller, Edmond S. Chan, Scott B. Cameron, Elissa M. Abrams, Sandeep Kapur, Stuart C. Carr, Timothy K. Vander Leek	0
2	Real-world experience: a retrospective pediatric chart review to determine why patients and caregivers discontinue oral immunotherapy 2024 ·Allergy Asthma and Clinical Immunology ·(unknown), Scott B. Cameron, (unknown), Mariam Hanna, Douglas P. Mack, Victoria E. Cook	0
3	Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral Immunotherapy 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Carina Venter, (unknown), Philippe Bégin, Scott B. Cameron, Edmond S. Chan, Victoria E. Cook, Jeffrey M. Factor, Marion Groetch, Mariam Hanna, Douglas H. Jones, Richard L. Wasserman, Douglas P. Mack	8
4	Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature 2023 ·SHILAP Revista de lepidopterología ·(unknown), Samira Jeimy, Lianne Soller, (unknown), Elissa M. Abrams, Scott B. Cameron, Harold Kim, Edmond S. Chan	1
5	Risk factors associated with safety of preschool peanut oral immunotherapy 2023 ·SHILAP Revista de lepidopterología ·(unknown), Edmond S. Chan, Qian Zhang, Jeffrey N. Bone, Stuart C. Carr, Sandeep Kapur, (unknown), (unknown), Scott B. Cameron, Victoria E. Cook, Laura S. Leo, Tiffany Wong, Thomas Gerstner, (unknown), Elissa M. Abrams, Raymond Mak, (unknown), Lianne Soller	4
6	The Case for Prompt Salvage Infant Peanut Oral Immunotherapy Following Failed Primary Prevention 2022 ·The Journal of Allergy and Clinical Immunology In Practice ·Gilbert T. Chua, Matthew Greenhawt, Marcus Shaker, Lianne Soller, Elissa M. Abrams, Scott B. Cameron, Victoria E. Cook, (unknown), David M. Fleischer, Raymond Mak, Timothy K. Vander Leek, Edmond S. Chan	22
7	Web-based Infant Food Introduction (WIFI): Feasibility and satisfaction of virtual allergist-supervised food introduction 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), (unknown), Douglas P. Mack, Lianne Soller, Edmond S. Chan, Samira Jeimy, Mariam Hanna, Elissa M. Abrams, Scott B. Cameron, (unknown), (unknown), Jennifer L. P. Protudjer, Tiffany Wong	6
8	Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Lianne Soller, Stuart Carr, Sandeep Kapur, (unknown), (unknown), Victoria E. Cook, (unknown), Tiffany Wong, Timothy K. Vander Leek, Thomas Gerstner, (unknown), Elissa M. Abrams, Raymond Mak, Kyla J. Hildebrand, (unknown), Scott B. Cameron, Edmond S. Chan	29
9	How to Incorporate Oral Immunotherapy into Your Clinical Practice 2021 ·Current Allergy and Asthma Reports ·Elissa M. Abrams, (unknown), Scott B. Cameron, Lianne Soller, Edmond S. Chan	16
10	Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies 2020 ·Cancer Science ·Hironobu Minami, Toshihiko Doi, Masanori Toyoda, Yoshinori Imamura, Naomi Kiyota, Ayako Mitsuma, Tomoya Shimokata, Yoichi Naito, Nobuaki Matsubara, Takeshi Tajima, (unknown), (unknown), Scott B. Cameron, Yuichi Ando	6
11	First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy 2019 ·The Journal of Allergy and Clinical Immunology In Practice ·Lianne Soller, Elissa M. Abrams, Stuart Carr, Sandeep Kapur, (unknown), (unknown), (unknown), (unknown), Timothy K. Vander Leek, (unknown), Tiffany Wong, Victoria E. Cook, Kyla J. Hildebrand, Thomas Gerstner, Raymond Mak, (unknown), Scott B. Cameron, Edmond S. Chan	78
12	Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial 2018 ·Journal of Clinical Oncology ·Aditya Bardia, Marina Parton, Sherko Kümmel, Laura García‐Estévez, Chiun‐Sheng Huang, Javier Cortés, Manuel Ruíz‐Borrego, Melinda L. Telli, Paloma Martín-Martorell, Rafael López‐López, J. Thaddeus Beck, Roohi Ismail‐Khan, Shin‐Cheh Chen, Sara A. Hurvitz, Ingrid A. Mayer, D. Carreon, Scott B. Cameron, Serena G. Liao, José Baselga, Sung‐Bae Kim	55
13	Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects 2013 ·The Journal of Clinical Pharmacology ·Shyeilla V. Dhuria, Heidi J. Einolf, James B. Mangold, (unknown), Helen Gu, Lai Wang, Scott B. Cameron	17
14	Microsoft SQL Server 2008 Analysis Services 2009 ·Scott B. Cameron	6
15	Intravascular hemolysis following low dose daily rifampin 2008 ·Pediatric Blood & Cancer ·Cindy Neunert, Geeta Paranjape, Scott B. Cameron, Zora R. Rogers	6
16	Screening of compounds toxicity against human Monocytic cell line-THP-1 by flow cytometry 2004 ·Biological Procedures Online ·Neora Pick, Scott B. Cameron, Dorit Arad, Yossef Av‐Gay	37
17	T helper cell polarisation as a measure of the maturation of the immune response 2003 ·Mediators of Inflammation ·Scott B. Cameron, Ellen H. Stolte, Anthony W. Chow, Huub F. J. Savelkoul	5
18	Temporal Sequence and Functional Implications of Vβ‐Specific T Cell Receptor Down‐regulation and Costimulatory Molecule Expression following In Vitro Stimulation with the Staphylococcal Superantigen Toxic Shock Syndrome Toxin–1 2002 ·The Journal of Infectious Diseases ·Winnie W. S. Kum, Ryan Hung, Scott B. Cameron, Anthony W. Chow	7
19	Temporal Sequence and Kinetics of Proinflammatory and Anti-Inflammatory Cytokine Secretion Induced by Toxic Shock Syndrome Toxin 1 in Human Peripheral Blood Mononuclear Cells 2001 ·Infection and Immunity ·Winnie W. S. Kum, Scott B. Cameron, Ryan Hung, Shirin Kalyan, Anthony W. Chow	42
20	Stool Carriage, Clinical Isolation, and Mortality During an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients 1995 ·Clinical Infectious Diseases ·C. L. Wells, Billie A. Juni, Scott B. Cameron, (unknown), David L. Dunn, Patricia Ferrieri, Frank S. Rhame	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact